Find clinical trials for small cell lung cancer. Search for small cell lung cancer clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 642
Active & Responsive
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
for
Small-cell Lung Cancer
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT04342429
Recruiting
Active & Responsive
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT05787587
Phase1, Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,
Sponsor: Alterome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06835569
Phase1, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Lincoln NE, Reno NV
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & ResponsiveNew
A 2-part Phase 1/2 Open-label Trial on ODM-212
for
Mesothelioma, Pancreatic Cancer,
Location: Fairfax VA, Irving TX
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT07563738
Phase1, Phase2, Recruiting
Active & Responsive
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
for
Solid Tumors, Gastric Cancer,
Location: Fairfax VA, Margate FL, Greenville SC, Memphis TN,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18+
Code: NCT06710132
Phase1, Phase2, Recruiting
Active & Responsive
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
for
Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT05800587
Phase2, Recruiting
Active & Responsive
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Location: Fairfax VA, Huntersville NC, Nashville TN,